Intellia Therapeutics, Inc. (NASDAQ:NTLA) appears in 286 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 1,001,032 | 10.79% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 1,965,181 | 17.79% | $0.00 |
| ARK Investment Management LLC | 31 Dec, 2025 | 0 | 2,288,146 | 19.20% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -269,781 | -34.54% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 1,447,967 | 29.13% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | -248,634 | -22.44% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 142,495 | 103.30% | $0.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 0 | 3,102,664 | 139.23% | $0.00 |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 31 Dec, 2025 | 0 | 236,953 | 47.92% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | 47,329 | 86.74% | $0.00 |
| Regeneron Pharmaceuticals, Inc. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Contrarius Group Holdings Ltd | 31 Dec, 2025 | 0 | -5,175,456 | -87.87% | $0.00 |
| PEAK6 LLC | 31 Dec, 2025 | 0 | 748 | 0.00% | $0.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 0 | 249,131 | 10.17% | $0.00 |
| Marex Group plc | 31 Dec, 2025 | 0 | 1,001 | 0.16% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 107,333 | 4.15% | $0.00 |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 31 Dec, 2025 | 0 | 13,432 | 2.38% | $0.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 0 | 182,900 | 8.45% | $0.00 |
| Vestmark Advisory Solutions, Inc. | 31 Dec, 2025 | 0 | 146,361 | 49.19% | $0.00 |
| Morgan Stanley | 31 Dec, 2025 | 0 | -3,694,724 | -61.35% | $0.00 |